title: [Effects of mitomycin C perfusion after bladder tumor surgery].
abstract: In the last ten years, 26 cases of bladder tumor in T1-T2 stage have been given Mitomycin C perfusion in cava after operation to prevent tumor recurrence. The results of follow-up for one to eight years showed no recurrence occurred in all 26 cases with Mitomycin C perfusion and in control group (64 cases) 14 had recurrence. The authors consider that Mitomycin C perfusion in a long time is effective for the prevention of recurrence of bladder tumor. The methods and untoward effects of Mitomycin C perfusion are discussed in this article.
authors.forename: C L
authors.initials: CL
authors.lastname: Zhou
mesh_terms: D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D010478:Chemotherapy, Cancer, Regional Perfusion; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage*; D011184:Postoperative Period; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
chemical_list: D008937:Mitomycins; D016685:Mitomycin